DCGI Mulls Response Plan For India-Made Drugs Subject Of Foreign Alerts
This article was originally published in PharmAsia News
Executive Summary
The Drug Controller General of India is drafting a policy to make it clear to drug makers its response to safety alerts issued by regulators in other countries concerned with India-produced drugs.